Adjusting dosages should always be under medical supervision to ensure efficacy and safety
Available from: Keller LA, Keller KM, Monge MP, Pereyra CM, Alonso VA, Cavaglieri LR, et al
The largest cohort study to date, published in JAMA in 2011 (N = 443,198 adults aged 25 to 64), found no increase in the risk of myocardial infarction, sudden cardiac death, or stroke among current users of ADHD stimulants compared to nonusers (adjusted rate ratio 0.83, 95% CI 0.72 to 0.96) [6]
Indeed, a recent perspective in Nature Sustainability warns that peptide drugs like GLP-1 agonists generate unsustainable volumes of toxic waste and non-degradable solid supports ( [20] )
People tracking tirzepatide results who incorporate both levocarnitine and resistance training would be optimizing from multiple angles simultaneously